Sterling Pharma Solutions granted MIA license for cGMP antibody-drug conjugate manufacturing at UK facility 20-Apr-2023 By Rachel Arthur CDMO Sterling Pharma Solutions has been granted a Manufacturer’s Authorisation for Investigational Medicinal Products from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA).
Sterling begins large-scale silica production for Nanologica 29-Aug-2019 By Vassia Barba Sterling begins manufacturing of $14m worth of silica particles as preparative chromatography media, after deal with Chinese distributor.